Vaccine equity in low and middle income countries: a systematic review and meta-analysis

HA Ali, AM Hartner, S Echeverria-Londono… - International journal for …, 2022 - Springer
Background Evidence to date has shown that inequality in health, and vaccination coverage
in particular, can have ramifications to wider society. However, whilst individual studies have …

COVID‐19 vaccinations: the unknowns, challenges, and hopes

K Mohamed, P Rzymski, MS Islam… - Journal of medical …, 2022 - Wiley Online Library
The entire world has been suffering from the coronavirus disease 2019 (COVID‐19)
pandemic since March 11, 2020. More than a year later, the COVID‐19 vaccination brought …

Oral antiviral treatments for COVID-19: opportunities and challenges

L Rahmah, SO Abarikwu, AG Arero, M Essouma… - Pharmacological …, 2022 - Springer
The use of antiviral COVID-19 medications can successfully inhibit SARS-CoV-2 replication
and prevent disease progression to a more severe form. However, the timing of antiviral …

Key considerations during the transition from the acute phase of the COVID-19 pandemic: a narrative review

P Rzymski, M Pokorska-Śpiewak, T Jackowska… - Vaccines, 2023 - mdpi.com
The COVID-19 pandemic has been met with an unprecedented response from the scientific
community, leading to the development, investigation, and authorization of vaccines and …

[HTML][HTML] Efficacy of mRNA, adenoviral vector, and perfusion protein COVID-19 vaccines

MR Zinatizadeh, PK Zarandi, M Zinatizadeh… - Biomedicine & …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19) has a devastating impact on global
populations triggered by a highly infectious viral sickness, produced by the severe acute …

[HTML][HTML] The biomedical potential of tardigrade proteins: A review

N Kasianchuk, P Rzymski, Ł Kaczmarek - Biomedicine & Pharmacotherapy, 2023 - Elsevier
Tardigrades are ubiquitous microinvertebrates exhibiting extreme tolerance to various
environmental stressors like low and high temperatures, lack of water, or high radiation …

Prevalence and drivers of COVID-19 vaccine booster hesitancy among German university students and employees

S Attia, K Mausbach, M Klugar, HP Howaldt… - Frontiers in public …, 2022 - frontiersin.org
COVID-19 booster hesitancy (VBH) is a serious public health challenge which acts
simultaneously with the waning vaccine-elicited immunity and the emerging viral variants to …

COVID‐19 vaccinations and rates of infections, hospitalizations, ICU admissions, and deaths in Europe during SARS‐CoV‐2 Omicron wave in the first quarter of 2022

P Rzymski, N Kasianchuk, D Sikora… - Journal of Medical …, 2023 - Wiley Online Library
The vaccination campaigns brought hope to minimizing the coronavirus disease 2019
(COVID‐19) burden. However, the emergence of novel, highly transmissible Omicron …

Immunogenicity and safety of homologous and heterologous prime–boost immunization with COVID-19 vaccine: systematic review and meta-analysis

H Cheng, Z Peng, S Si, X Alifu, H Zhou, P Chi… - Vaccines, 2022 - mdpi.com
A prime–boost strategy of COVID-19 vaccines brings hope to limit the spread of SARS-CoV-
2, while the immunogenicity of the vaccines is waning over time. Whether a booster dose of …

COVID-19 vaccination and rates of infections, hospitalizations, ICU admissions, and deaths in the European Economic Area during autumn 2021 wave of SARS-CoV …

D Sikora, P Rzymski - Vaccines, 2022 - mdpi.com
The COVID-19 vaccination campaigns were met with a varying level of vaccine hesitancy in
Europe. We analyzed the potential relationships between COVID-19 vaccine coverage in …